Viking Therapeutics, Inc. (VKTX) Ownership
VKTX ownership summary
as of October 18, 2026- Institutions
- 60.5% of shares outstanding
- Insiders
- 2.84% of shares outstanding
- Shares outstanding
- 127.2M
- Float
- 113.7M shares available to trade
- Short interest
- 21.44% 25.9M shares short
- Days to cover
- 3.66 short interest up 14.8% vs prior month
- Institutions 60.47%
- Insiders 2.84%
- Other investors 36.69%
VKTX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | FMR Inc | 4.98% | 6.3M | $159.5M | +311,003 (+5.2%) | June 30, 2026 |
| 2 | BlackRock Inc | 4.87% | 6.2M | $155.8M | −690,641 (−10.0%) | June 30, 2026 |
| 3 | State Street Corp | 4.41% | 5.6M | $141.1M | +1.2M (+27.5%) | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 3.97% | 5.1M | $127.2M | +41,161 (+0.8%) | June 30, 2026 |
| 5 | Vanguard Portfolio Management, LLC | 3.53% | 4.5M | $112.9M | +19,965 (+0.4%) | June 30, 2026 |
| 6 | Two Sigma Investments LLC | 3.10% | 3.9M | $99.1M | −494,728 (−11.2%) | June 30, 2026 |
| 7 | Morgan Stanley - Brokerage Accounts | 2.74% | 3.5M | $87.7M | +472,112 (+15.7%) | June 30, 2026 |
| 8 | Ameriprise Financial Inc | 1.70% | 2.2M | $54.3M | +477,338 (+28.4%) | June 30, 2026 |
| 9 | Geode Capital Management, LLC | 1.65% | 2.1M | $52.8M | +15,914 (+0.8%) | June 30, 2026 |
| 10 | American Century Companies Inc | 1.43% | 1.8M | $45.7M | −262,527 (−12.6%) | June 30, 2026 |
| 11 | D. E. Shaw & Co LP | 1.26% | 1.6M | $40.4M | −70,719 (−4.2%) | June 30, 2026 |
| 12 | BNP Paribas Arbitrage, SA | 0.77% | 982K | $24.7M | +441,201 (+81.6%) | June 30, 2026 |
| 13 | Citadel Advisors Llc | 0.75% | 952K | $23.9M | −310,706 (−24.6%) | June 30, 2026 |
| 14 | The Goldman Sachs Group Inc | 0.74% | 943K | $23.7M | −17,729 (−1.8%) | June 30, 2026 |
| 15 | UBS Group AG | 0.74% | 936K | $23.6M | −411,417 (−30.5%) | June 30, 2026 |
| 16 | JPMorgan Chase & Co | 0.72% | 915K | $23.0M | +429,482 (+88.4%) | June 30, 2026 |
| 17 | Jane Street Group LLC | 0.71% | 900K | $22.6M | +150,609 (+20.1%) | June 30, 2026 |
| 18 | Susquehanna International Group, LLP | 0.64% | 816K | $20.5M | +110,558 (+15.7%) | June 30, 2026 |
| 19 | Vanguard Fiduciary Trust Co | 0.58% | 732K | $18.4M | +21,635 (+3.0%) | June 30, 2026 |
| 20 | Charles Schwab Investment Management Inc | 0.57% | 731K | $18.4M | −5,775 (−0.8%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 3.7M shares and 8 cut 2.3M.
VKTX top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.76% | 3.5M | $88.3M | −5,218 (−0.1%) | August 31, 2026 |
| 2 | State Street® SPDR® S&P® Biotech ETF | 2.73% | 3.5M | $87.3M | −66,000 (−1.9%) | September 30, 2026 |
| 3 | Vanguard Small Cap Index | 2.09% | 2.7M | $67.0M | +124,284 (+4.9%) | September 30, 2026 |
| 4 | Vanguard MStar Small Cap Growth Indx Inv | 1.17% | 1.5M | $37.3M | +22,972 (+1.6%) | September 30, 2026 |
| 5 | Jupiter Merian Glb Eq Abs Rt I USD Acc | 1.02% | 1.3M | $32.7M | +1.3M (0.0%) | December 31, 2025 |
| 6 | American Century Heritage Inv | 0.92% | 1.2M | $29.3M | −167,816 (−12.6%) | September 30, 2026 |
| 7 | Fidelity Advisor Growth Opps M | 0.84% | 1.1M | $26.7M | — | August 31, 2026 |
| 8 | CT (Lux) American Smaller Com 9U USD | 0.56% | 718K | $18.1M | −239,209 (−25.0%) | August 31, 2026 |
| 9 | Schwab US Small-Cap ETF™ | 0.52% | 656K | $16.5M | +441 (+0.1%) | September 30, 2026 |
| 10 | Fidelity Extended Market Index | 0.45% | 569K | $14.3M | −6,369 (−1.1%) | August 31, 2026 |
| 11 | Fidelity Select Health Care | 0.42% | 540K | $13.6M | — | August 31, 2026 |
| 12 | Fidelity Stock Selector Small Cap | 0.42% | 537K | $13.5M | — | July 31, 2026 |
| 13 | iShares Russell Mid-Cap ETF | 0.37% | 466K | $11.7M | +855 (+0.2%) | September 30, 2026 |
| 14 | Fidelity Advisor Biotechnology I | 0.35% | 450K | $11.3M | — | August 31, 2026 |
| 15 | Vanguard Explorer Inv | 0.35% | 444K | $11.2M | — | June 30, 2026 |
| 16 | Pictet-Biotech P USD | 0.35% | 441K | $11.1M | −1,788 (−0.4%) | June 30, 2026 |
| 17 | Fidelity Mid Cap Index | 0.34% | 430K | $10.8M | +1,110 (+0.3%) | August 31, 2026 |
| 18 | CT American Smaller Coms(US) InstAccGBP | 0.34% | 430K | $10.8M | −145,396 (−25.3%) | August 31, 2026 |
| 19 | Fidelity Select Biotechnology | 0.33% | 419K | $10.6M | +5,000 (+1.2%) | August 31, 2026 |
| 20 | Columbia Acorn Inst | 0.29% | 366K | $9.2M | −177,193 (−32.6%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
VKTX insider transactions
latest 12| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | Neil William Aubuchon | Buy | $33.50 | 4,475 | $149,912 |
| 2026-01-05 | Brian Lian | Sell | $32.96 | 233,409 | $7.7M |
| 2026-01-05 | Greg Zante | Sell | $32.90 | 57,661 | $1.9M |
| 2026-01-05 | Marianna Mancini | Sell | $32.98 | 57,661 | $1.9M |
| 2026-01-02 | Matthew W Foehr | Sell | $35.11 | 16,000 | $561,760 |
| 2025-10-28 | Brian Lian | Sell | $35.01 | 38,989 | $1.4M |
| 2025-10-28 | Greg Zante | Sell | $35.00 | 6,185 | $216,475 |
| 2025-10-28 | Marianna Mancini | Sell | $35.00 | 6,185 | $216,475 |
| 2025-10-27 | Charles A Rowland Jr | Sell | $35.57 | 60,000 | $2.1M |
| 2025-07-03 | Brian Lian | Sell | $27.80 | 26,889 | $747,514 |
| 2025-07-03 | Greg Zante | Sell | $27.76 | 4,266 | $118,424 |
| 2025-07-03 | Marianna Mancini | Sell | $27.77 | 4,266 | $118,467 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VKTX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VKTX
Institutional investors own 60.5% of Viking Therapeutics's shares and insiders 2.84%. The largest holder is FMR Inc with 4.98% of the shares (6.3M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 8 reduced their stake in the latest filings. Short interest is 21.44% of the float, or 3.66 days of average trading volume. The share count rose 2,545.2% since 2014.
Related: VKTX analyst forecast, VKTX key metrics. See the VKTX stock overview for the latest quote and news.
VKTX ownership FAQ
Who owns the most Viking Therapeutics stock?
The largest shareholders of Viking Therapeutics are FMR Inc (4.98%), BlackRock Inc (4.87%), State Street Corp (4.41%), Vanguard Capital Management, LLC (3.97%), Vanguard Portfolio Management, LLC (3.53%).
What percentage of Viking Therapeutics is owned by institutions?
Institutions hold 60.5% of Viking Therapeutics's shares outstanding; insiders hold 2.84%.
Which funds own Viking Therapeutics?
The largest fund holders of Viking Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.76%), State Street® SPDR® S&P® Biotech ETF (2.73%), Vanguard Small Cap Index (2.09%), Vanguard MStar Small Cap Growth Indx Inv (1.17%), Jupiter Merian Glb Eq Abs Rt I USD Acc (1.02%).
What is Viking Therapeutics's short interest?
25.9M shares of Viking Therapeutics were sold short, 21.44% of the float; at the average daily volume it would take 3.66 days to cover.
Are insiders buying or selling Viking Therapeutics?
Of the latest 12 reported insider transactions in Viking Therapeutics (since July 3, 2025), 1 were purchases and 11 were sales.
How many shares of Viking Therapeutics are outstanding?
Viking Therapeutics has 127.2M shares outstanding, of which 113.7M are in the public float.